Pulmonary Hypertension and Anastrozole Trial

  • STATUS
    Recruiting
  • participants needed
    84
  • sponsor
    University of Pennsylvania
Updated on 22 January 2022
hypertension
pulmonary function test
heart disease
pulmonary disease
connective tissue disease
interstitial lung disease
left ventricular end-diastolic pressure

Summary

The primary objectives of this study are to determine whether the study drug, anastrozole may improve six minute walk distance at six months compared to placebo and to assess safety and side effects up to twelve months in pulmonary arterial hypertension (PAH).

Details
Condition Pulmonary Arterial Hypertension
Treatment anastrozole, Placebo Oral Tablet
Clinical Study IdentifierNCT03229499
SponsorUniversity of Pennsylvania
Last Modified on22 January 2022

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note